BNP Paribas Discount Zert MHL 30..../ DE000PC2LN31 /
2024-05-14 9:20:15 AM | Chg.+0.080 | Bid9:38:33 AM | Ask9:38:33 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
311.830EUR | +0.03% | 311.840 Bid Size: 48 |
312.760 Ask Size: 48 |
S+P GLOBAL INC. ... | - - | 2024-12-30 | Call |
GlobeNewswire
9:00 AM
AbbeyCross Emerging Market FX payments platform hits key milestone: Launch of ABX Studio with US Tie...
GlobeNewswire
9:00 AM
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire
7:15 AM
Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination wit...
GlobeNewswire
7:06 AM
OKX Wallet Announces Integration of KyberSwap for Enhanced Decentralized Trading
GlobeNewswire
6:00 AM
SPEE3D LAUNCHES EXPEDITIONARY MANUFACTURING UNIT (EMU) – THE COMPLETE MOBILE ADDITIVE MANUFACTURING ...
GlobeNewswire
5:01 AM
MKS Instruments Announces Pricing of Upsized Private Offering of $1.2 Billion of 1.25% Convertible S...
GlobeNewswire
3:50 AM
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
3:00 AM
Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial Results on May 14, 2024
GlobeNewswire
3:00 AM
GLOBAL LIFE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Bee...
GlobeNewswire
2:00 AM
ROSEN, A LEADING LAW FIRM, Encourages Rivian Automotive, Inc. Investors With Losses in Excess of $10...
GlobeNewswire
2:00 AM
HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- an...
GlobeNewswire
2:00 AM
HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatme...
GlobeNewswire
12:15 AM
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2024
GlobeNewswire
12:00 AM
ARMLOGI HOLDING CORP. ANNOUNCES PRICING OF $8 MILLION INITIAL PUBLIC OFFERING